5-Amino-1MQ.
5-Amino-1MQ is a small molecule NNMT inhibitor. With the molecular formula C₁₁H₁₁N and a molecular weight of 217.22 g/mol (CAS: 42464-96-0), it is characterized in foundational biochemical research.
Lab Verified
Clinical Grade
PMID Cited
Mechanism of Action.
Published preclinical research has characterized the following molecular pathways and receptor interactions for 5-Amino-1MQ.
Nicotinamide N-methyltransferase (NNMT)
Published research demonstrates 5-Amino-1MQ modulates targeted signaling cascades within cell tissue models.
Cellular NAD+ Pathway
In cellular environments, 5-Amino-1MQ exhibits selective binding and corresponding pathway activation.
Clinical Literature
Research review on 5-Amino-1MQ molecular characterization.
Preclinical studies have characterized the molecular properties and receptor binding profiles of 5-Amino-1MQ in standardized assay systems.
5-Amino-1MQ structure-activity relationship analysis.
Structure-activity relationship studies have examined the functional domains and binding characteristics of 5-Amino-1MQ in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
Related Compounds.
MetabolicAICAR
$57.00C9H14N4O5 · 258.23 g/mol
For in vitro research use only. Not for human consumption.
MetabolicAOD9604
$48.00C78H123N23O23S2 · 1815.12 g/mol
For in vitro research use only. Not for human consumption.
MetabolicCagrilintide
$62.00C194H312N54O59S2 · 4409.01 g/mol
For in vitro research use only. Not for human consumption.